WEIXIA GUO
Prescription History 1407219421
Internal Medicine - Rheumatology in Ypsilanti, MI
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for WEIXIA GUO, an active Rheumatology specialist practicing in Ypsilanti, MI. Our medical registry currently tracks 18 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,319 documented patient claims. Among these therapy options, the most frequently utilized medication is Prednisone, which accounts for 379 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MI PrescribersVs. MI Avg |
|---|---|---|---|
| Prednisone | 379 | $10.63 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 379 Medicare prescriptions for Prednisone, about 8.1 times the volume of the typical Michigan prescriber of this medication (46.6). Medicare paid an average of $10.63 per fill, versus $4.15 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 664.8 30-Day Fills standardized to 30-day supplies 18,824 Days of Medication total across all patients in 2024 | |||
| MethotrexateMethotrexate Sodium | 295 | $41.58 | ▲ More than typical |
About Methotrexate: Methotrexate is used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma), severe psoriasis that has not responded to other treatments, or rheumatoid arthritis. Show more ▾ It may also be used to treat a certain type of arthritis in children (polyarticular juvenile idiopathic arthritis - pJIA). Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and blocking the immune system from attacking healthy tissue. Early treatment of rheumatoid arthritis with methotrexate helps to reduce further joint damage and to preserve joint function. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. In 2024, this provider wrote 295 Medicare prescriptions for Methotrexate, about 3 times the volume of the typical Michigan prescriber of this medication (98.4). Medicare paid an average of $41.58 per fill, versus $36.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 614.6 30-Day Fills standardized to 30-day supplies 18,139 Days of Medication total across all patients in 2024 | |||
| Hydroxychloroquine Sulfate | 232 | $74.58 | ▲ More than typical |
About Hydroxychloroquine Sulfate: Hydroxychloroquine is used to prevent or treat malaria caused by mosquito bites. Show more ▾ The United States Center for Disease Control provides updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. Discuss the most recent information with your doctor before traveling to areas where malaria occurs. This medication is also used to treat certain auto-immune diseases (lupus, rheumatoid arthritis). It belongs to a class of medications known as disease-modifying antirheumatic drugs (DMARDs). It can reduce skin problems in lupus and prevent swelling/pain in arthritis. Hydroxychloroquine is not recommended for coronavirus infection, also known as COVID-19, unless you are enrolled in a study. Talk to your doctor about the risks and benefits. A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) In 2024, this provider wrote 232 Medicare prescriptions for Hydroxychloroquine Sulfate, about 2.8 times the volume of the typical Michigan prescriber of this medication (83.8). Medicare paid an average of $74.58 per fill, versus $57.73 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 628.9 30-Day Fills standardized to 30-day supplies 18,866 Days of Medication total across all patients in 2024 | |||
| Allopurinol | 72 | $9.98▼ below MI avg | ▲ More than typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2024, this provider wrote 72 Medicare prescriptions for Allopurinol, about 1.5 times the volume of the typical Michigan prescriber of this medication (47.5). Medicare paid an average of $9.98 per fill, versus $12.68 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 187 30-Day Fills standardized to 30-day supplies 5,610 Days of Medication total across all patients in 2024 | |||
| Humira(Cf) PenAdalimumab | 68 | $8,661.14 | ▲ More than typical |
About Humira(Cf) Pen: Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). Show more ▾ This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis). This monograph is about the following adalimumab products: adalimumab, adalimumab-aacf, adalimumab-aaty, adalimumab-adaz, adalimumab-adbm, adalimumab-afzb, adalimumab-aqvh, adalimumab-atto, adalimumab-bwwd, adalimumab-fkjp, and adalimumab-ryvk. A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS. In 2024, this provider wrote 68 Medicare prescriptions for Humira(Cf) Pen, about 1.6 times the volume of the typical Michigan prescriber of this medication (42.7). Medicare paid an average of $8,661.14 per fill, versus $8,528.20 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 81.4 30-Day Fills standardized to 30-day supplies 2,324 Days of Medication total across all patients in 2024 | |||
| Leflunomide | 45 | $44.71▼ below MI avg | ▼ Less than typical |
About Leflunomide: This medication is used to treat rheumatoid arthritis, a condition in which the body's defense system (immune system) fails to recognize the body as itself and attacks the healthy tissues around the joints. Show more ▾ Leflunomide helps to reduce the joint damage/pain/swelling and helps you to move better. It works by weakening your immune system and decreasing swelling (inflammation). An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS. In 2024, this provider wrote 45 Medicare prescriptions for Leflunomide, about 68% of the volume of the typical Michigan prescriber of this medication (65.8). Medicare paid an average of $44.71 per fill, versus $66.17 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 104.5 30-Day Fills standardized to 30-day supplies 3,130 Days of Medication total across all patients in 2024 | |||
| Enbrel SureclickEtanercept | 31 | $7,087.29▼ below MI avg | ▼ Less than typical |
About Enbrel Sureclick: This medication is used alone or in combination with an immunosuppressant (such as methotrexate) to treat certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis). Show more ▾ Some brands of this medication are also used to treat a skin condition called psoriasis. These conditions are caused by an overactive immune system (autoimmune disease). The immune system attacks the body's own healthy cells, causing inflammation in the joints and skin. Etanercept controls your body's defensive response by blocking the action of a certain natural substance (TNF) that is used by the immune system. Treatment decreases redness, itching and scaly patches in psoriasis as well as the pain, swelling and stiffness of joints in arthritis. This medication can stop the progression of disease and joint damage, resulting in improved daily functioning and quality of life. This medication treats but does not cure autoimmune diseases. Symptoms usually return within 1 month of stopping the medication. A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS. In 2024, this provider wrote 31 Medicare prescriptions for Enbrel Sureclick, about half the volume of the typical Michigan prescriber of this medication (58.3). Medicare paid an average of $7,087.29 per fill, versus $7,640.52 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 31 30-Day Fills standardized to 30-day supplies 868 Days of Medication total across all patients in 2024 | |||
| Methylprednisolone | 27 | $18.93 | ≈ Typical |
About Methylprednisolone: Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. Show more ▾ It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders. A PREDNISOLONE derivative with similar anti-inflammatory action. In 2024, this provider wrote 27 Medicare prescriptions for Methylprednisolone, about 75% of the volume of the typical Michigan prescriber of this medication (35.9). Medicare paid an average of $18.93 per fill, versus $6.14 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 42.5 30-Day Fills standardized to 30-day supplies 1,043 Days of Medication total across all patients in 2024 | |||
| Sulfasalazine | 22 | $35.59 | ▼ Less than typical |
About Sulfasalazine: Sulfasalazine is used to treat a certain type of bowel disease called ulcerative colitis. Show more ▾ This medication does not cure this condition, but it helps decrease symptoms such as fever, stomach pain, diarrhea, and rectal bleeding. After an attack is treated, sulfasalazine is also used to increase the amount of time between attacks. This medication works by reducing irritation and swelling in the large intestines. In addition, delayed-release tablets of sulfasalazine are used to treat rheumatoid arthritis. Sulfasalazine helps to reduce joint pain, swelling, and stiffness. Early treatment of rheumatoid arthritis with sulfasalazine helps to reduce/prevent further joint damage so you can do more of your normal daily activities. This medication is used with other drugs, rest, and physical therapy in patients who have not responded to other medications (salicylates, nonsteroidal anti-inflammatory drugs-NSAIDs). A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) In 2024, this provider wrote 22 Medicare prescriptions for Sulfasalazine, about 62% of the volume of the typical Michigan prescriber of this medication (35.3). Medicare paid an average of $35.59 per fill, versus $33.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45.1 30-Day Fills standardized to 30-day supplies 1,354 Days of Medication total across all patients in 2024 | |||
| Actemra ActpenTocilizumab | 22 | $5,430.08 | ≈ Typical |
About Actemra Actpen: This medication is used to treat rheumatoid arthritis in adults and in children (such as polyarticular juvenile idiopathic arthritis-PJIA, systemic juvenile idiopathic arthritis-SJIA). Show more ▾ It helps to reduce pain and swelling due to rheumatoid arthritis. Tocilizumab is used to treat giant cell arteritis. It helps to reduce swelling in your blood vessels so blood can flow more easily. This medication is also used to slow down the decrease in lung function in people with a certain type of lung disease (systemic sclerosis-associated interstitial lung disease - SSc-ILD). Tocilizumab belongs to a class of drugs known as Interleukin-6 (IL-6) blockers. It works by blocking IL-6, a substance made by the body that causes swelling (inflammation). This monograph is about the following tocilizumab products: tocilizumab and tocilizumab-aazg. A humanised anti-interleukin-6 receptor monoclonal antibody. In 2024, this provider wrote 22 Medicare prescriptions for Actemra Actpen, about the same volume as the typical Michigan prescriber of this medication (24.3). Medicare paid an average of $5,430.08 per fill, versus $4,177.56 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25.6 30-Day Fills standardized to 30-day supplies 728 Days of Medication total across all patients in 2024 | |||
| Taltz AutoinjectorIxekizumab | 22 | $8,645.45 | ▲ More than typical |
About Taltz Autoinjector: This medication is used to treat plaque psoriasis and certain types of arthritis (psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis). Show more ▾ Ixekizumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-17A) that may cause inflammation and swelling. A humanized anti-interleukin 17 monoclonal antibody used for the treatment of PSORIASIS. In 2024, this provider wrote 22 Medicare prescriptions for Taltz Autoinjector, about 1.3 times the volume of the typical Michigan prescriber of this medication (17.1). Medicare paid an average of $8,645.45 per fill, versus $7,448.96 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 616 Days of Medication total across all patients in 2024 | |||
| Folic Acid | 21 | $7.80 | ▼ Less than typical |
About Folic Acid: Folic acid is the man-made form of folate. Show more ▾ Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells. Folic acid supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of folic acid either through their diet or supplements to prevent infant spinal cord birth defects. A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. In 2024, this provider wrote 21 Medicare prescriptions for Folic Acid, about 74% of the volume of the typical Michigan prescriber of this medication (28.5). Medicare paid an average of $7.80 per fill, versus $6.26 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 63 30-Day Fills standardized to 30-day supplies 1,890 Days of Medication total across all patients in 2024 | |||
| Cosentyx Sensoready PenSecukinumab | 17 | $7,646.58▼ below MI avg | ≈ Typical |
About Cosentyx Sensoready Pen: This medication is used to treat plaque psoriasis and certain types of arthritis (such as arthritis of the spine, psoriatic arthritis, axial spondyloarthritis, enthesitis-related arthritis). Show more ▾ It is also used to treat a certain skin disorder (hidradenitis suppurativa). Secukinumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-17A) that may cause inflammation and swelling. A fully human antibody to interleukin-17A for treatment of psoriasis, rheumatoid arthritis, and uveitis. In 2024, this provider wrote 17 Medicare prescriptions for Cosentyx Sensoready Pen, about 89% of the volume of the typical Michigan prescriber of this medication (19.1). Medicare paid an average of $7,646.58 per fill, versus $9,100.15 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 17 30-Day Fills standardized to 30-day supplies 476 Days of Medication total across all patients in 2024 | |||
| EnbrelEtanercept | 16 | $7,190.00▼ below MI avg | ▼ Less than typical |
About Enbrel: This medication is used alone or in combination with an immunosuppressant (such as methotrexate) to treat certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis). Show more ▾ Some brands of this medication are also used to treat a skin condition called psoriasis. These conditions are caused by an overactive immune system (autoimmune disease). The immune system attacks the body's own healthy cells, causing inflammation in the joints and skin. Etanercept controls your body's defensive response by blocking the action of a certain natural substance (TNF) that is used by the immune system. Treatment decreases redness, itching and scaly patches in psoriasis as well as the pain, swelling and stiffness of joints in arthritis. This medication can stop the progression of disease and joint damage, resulting in improved daily functioning and quality of life. This medication treats but does not cure autoimmune diseases. Symptoms usually return within 1 month of stopping the medication. A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS. In 2024, this provider wrote 16 Medicare prescriptions for Enbrel, about 60% of the volume of the typical Michigan prescriber of this medication (26.6). Medicare paid an average of $7,190.00 per fill, versus $7,499.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 16 30-Day Fills standardized to 30-day supplies 448 Days of Medication total across all patients in 2024 | |||
| Dapsone | 16 | $62.11▼ below MI avg | ≈ Typical |
About Dapsone: This medication is used to treat a certain type of skin disorder (dermatitis herpetiformis). Show more ▾ It is also used with other drugs to treat Hansen's disease. Dapsone belongs to a class of drugs known as sulfones. It works by decreasing swelling (inflammation) and stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) In 2024, this provider wrote 16 Medicare prescriptions for Dapsone, about 82% of the volume of the typical Michigan prescriber of this medication (19.4). Medicare paid an average of $62.11 per fill, versus $80.87 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 18 30-Day Fills standardized to 30-day supplies 526 Days of Medication total across all patients in 2024 | |||
| Leucovorin Calcium | 12 | $34.74 | ▼ Less than typical |
About Leucovorin Calcium: This medication is used to treat or prevent serious blood cell disorders (such as thrombocytopenia, neutropenia, anemia) caused by certain drugs (folic acid antagonists such as methotrexate, trimethoprim, pyrimethamine). Show more ▾ The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. In 2024, this provider wrote 12 Medicare prescriptions for Leucovorin Calcium, about a third of the volume of the typical Michigan prescriber of this medication (38.2). Medicare paid an average of $34.74 per fill, versus $34.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33.6 30-Day Fills standardized to 30-day supplies 1,008 Days of Medication total across all patients in 2024 | |||
| Pregabalin | 11 | $11.46▼ below MI avg | ▼ Less than typical |
About Pregabalin: This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. Show more ▾ This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures). A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA. In 2024, this provider wrote 11 Medicare prescriptions for Pregabalin, about a quarter of the volume of the typical Michigan prescriber of this medication (44.6). Medicare paid an average of $11.46 per fill, versus $22.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
| Cevimeline Hcl | 11 | $235.41 | ▼ Less than typical |
About Cevimeline Hcl: This medication is used to treat symptoms of dry mouth due to a certain immune disease (Sjogren's syndrome). Show more ▾ Cevimeline belongs to a class of drugs known as cholinergic agonists. It works by stimulating certain nerves to increase the amount of saliva you produce, making it easier and more comfortable to speak and swallow. In 2024, this provider wrote 11 Medicare prescriptions for Cevimeline Hcl, about 62% of the volume of the typical Michigan prescriber of this medication (17.9). Medicare paid an average of $235.41 per fill, versus $180.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for WEIXIA GUO is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Rheumatology prescribing approach at this Ypsilanti, MI practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MI prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
